Salt: Hydroxyurea
Therapeutic Description: Cytostatics
Category: DNA reactive cytotoxic.
Pregnancy: Positive evidence of risk: Use only when no safer alternative exists for a serious problem.
Lactation: Contraindicated or not recommended.
Contraindications: Marked bone marrow depression; severe anaemia.
Precautions: Haematological monitoring including bone marrow; monitor hepatic and renal function; recent X-ray or cytostatic therapy; pre-menopausal women.
Chronic myeloid leukaemia; melanoma; recurrent, metastatic or inoperable carcinoma of the ovary.
Adults: Solid Tumours
Cytarabine, didanosine, stavudine.
Oedema, drowsiness, hallucinations, headache, dizziness, fever, chills, pruritus, rash, hyperuricaemia, GI upsets, dysuria, myelosuppression, liver enzyme elevation, peripheral neuropathy, renal impairment, dyspnoea, pulmonary fibrosis.
Strength Pack Size PKR
500 mg100's1329.86

Your medicine formula resulted in the following types of medicine type. Please select to proceed.